Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124
Managing your weight is rarely a simple journey. For years, patients and doctors have navigated complicated treatment plans. Often, these plans yielded mixed long-term results. Recently, a class of medications called GLP-1 receptor agonists completely changed the landscape of obesity…
A new study is raising eyebrows in both medical and public health circles. Specifically, researchers found that people currently taking GLP-1 receptor agonists appear significantly less likely to engage in violent behavior. This held even when those individuals drank heavily…
GLP-1 medications are opening up a completely new world of health and vitality for millions of people. Treatments like Ozempic, Wegovy, and Mounjaro have entirely revolutionized how we manage type 2 diabetes and obesity. By dramatically improving metabolic health, these…
Walk down any grocery store snack aisle today, and something has shifted. The options look different. The labels read differently. And the people buying them are thinking about food in ways they simply weren’t five years ago. A lot of…
Something unexpected is happening among people taking GLP-1 weight loss medications. Alongside the reduced appetite and gradual weight loss, many patients report a sudden, intense interest in fragrance. Doctors are starting to take notice. Physicians who prescribe drugs like Ozempic,…
Nourish pulled in $100 million in new funding, with Menlo Ventures writing the biggest check. That brings the company’s total value to $1.75 billion. The startup connects people with virtual dietitians through their health insurance, so patients pay little to…
For years, doctors treating obesity faced one big problem. They had no early sign to indicate whether a patient was heading toward real weight loss. That guesswork may finally have an answer. Fresh data from the OASIS 4 trial show…